Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Colorectal Neoplasms

  Free Subscription


5 Ann Surg Oncol
3 Anticancer Res
1 BMC Cancer
1 BMC Gastroenterol
1 Br J Cancer
1 Cancer
3 Cancer Lett
1 Clin Cancer Res
1 Clin Res Hepatol Gastroenterol
2 Curr Treat Options Oncol
4 Dis Colon Rectum
1 Eur J Cancer
4 Eur J Surg Oncol
2 Gastroenterology
32 Gastrointest Endosc
2 Gut
5 Int J Cancer
4 Int J Colorectal Dis
1 Int J Oncol
1 J Am Coll Surg
1 J Clin Oncol
2 J Natl Cancer Inst
4 J Surg Oncol
1 Lancet Oncol
3 Oncogene
2 Oncol Rep
3 PLoS One
1 Proc Natl Acad Sci U S A
1 World J Surg

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Surg Oncol

  1. TANI K, Itabashi M, Okuya K, Okita K, et al
    Feasibility of Pooled One-Step Nucleic Acid Amplification for Molecular Staging of Pathologically Node-Negative Colon Cancer: A Prospective Multicenter Study.
    Ann Surg Oncol. 2021 Jun 4. pii: 10.1245/s10434-021-10140.
    PubMed         Abstract available

  2. BHATT A, Rousset P, Benzerdjeb N, Kammar P, et al
    Clinical and Radiologic Predictors of a Pathologic Complete Response to Neoadjuvant Chemotherapy (NACT) in Patients Undergoing Cytoreductive Surgery for Colorectal Peritoneal Metastases: Results of a Prospective Multi-center Study.
    Ann Surg Oncol. 2021;28:3840-3849.
    PubMed         Abstract available

  3. LIU W, Zhang ZY, Yin SS, Yan K, et al
    Contrast-Enhanced Intraoperative Ultrasound Improved Sensitivity and Positive Predictive Value in Colorectal Liver Metastasis: a Systematic Review and Meta-Analysis.
    Ann Surg Oncol. 2021;28:3763-3773.
    PubMed         Abstract available

  4. RIESER CJ, Hoehn RS, Zenati M, Hall LB, et al
    Impact of Socioeconomic Status on Presentation and Outcomes in Colorectal Peritoneal Metastases Following Cytoreduction and Chemoperfusion: Persistent Inequalities in Outcomes at a High-Volume Center.
    Ann Surg Oncol. 2021;28:3522-3531.
    PubMed         Abstract available

  5. DIAZ-VICO T, Fernandez-Hevia M, Suarez-Sanchez A, Garcia-Gutierrez C, et al
    Complete Mesocolic Excision and D3 Lymphadenectomy versus Conventional Colectomy for Colon Cancer: A Systematic Review and Meta-Analysis.
    Ann Surg Oncol. 2021 Jun 4. pii: 10.1245/s10434-021-10186.
    PubMed         Abstract available

    Anticancer Res

  6. KEENAN BP, VAN Loon K, Khilnani AD, Fidelman N, et al
    Molecular and Radiological Features of Microsatellite Stable Colorectal Cancer Cases With Dramatic Responses to Immunotherapy.
    Anticancer Res. 2021;41:2985-2992.
    PubMed         Abstract available

  7. KURAMOCHI H, Yamada T, Yoshida Y, Matsuda A, et al
    The Pre-treatment Lymphocyte-to-Monocyte Ratio Predicts Efficacy in Metastatic Colorectal Cancer Treated With TAS-102 and Bevacizumab.
    Anticancer Res. 2021;41:3131-3137.
    PubMed         Abstract available

  8. KIMURA M, Usami E, Teramachi H, Yoshimura T, et al
    Risk-benefit Analysis of FOLFIRI Plus Ramucirumab/Aflibercept as a Third-line Treatment in Metastatic Colorectal Cancer.
    Anticancer Res. 2021;41:3091-3097.
    PubMed         Abstract available

    BMC Cancer

  9. NAKAJIMA H, Kotani D, Bando H, Kato T, et al
    REMARRY and PURSUIT trials: liquid biopsy-guided rechallenge with anti-epidermal growth factor receptor (EGFR) therapy with panitumumab plus irinotecan for patients with plasma RAS wild-type metastatic colorectal cancer.
    BMC Cancer. 2021;21:674.
    PubMed         Abstract available

    BMC Gastroenterol

  10. WANG Y, Wang G, Li Z, Ling H, et al
    Comparison of the operative outcomes and learning curves between laparoscopic and "Micro Hand S" robot-assisted total mesorectal excision for rectal cancer: a retrospective study.
    BMC Gastroenterol. 2021;21:251.
    PubMed         Abstract available

    Br J Cancer

  11. SEFRIOUI D, Beaussire L, Gillibert A, Blanchard F, et al
    CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC).
    Br J Cancer. 2021 Jun 10. pii: 10.1038/s41416-021-01431.
    PubMed         Abstract available


  12. KIM SR, Tone A, Kim RH, Cesari M, et al
    Performance characteristics of screening strategies to identify Lynch syndrome in women with ovarian cancer.
    Cancer. 2020 Aug 18. doi: 10.1002/cncr.33144.
    PubMed         Abstract available

    Cancer Lett

  13. SUI Q, Peng J, Han K, Lin J, et al
    Corrigendum to "Voltage-gated sodium channel Nav1.5 promotes tumor progression and enhances chemosensitivity to 5-fluorouracil in colorectal cancer" [Canc. Lett. 500 (2021) 119-131].
    Cancer Lett. 2021;516:57-60.

  14. LI W, Ma Y, He L, Li H, et al
    Protease-activated receptor 2 stabilizes Bcl-xL and regulates EGFR-targeted therapy response in colorectal cancer.
    Cancer Lett. 2021 Jun 4. pii: S0304-3835(21)00271.
    PubMed         Abstract available

  15. LI J, Tian L, Jing Z, Guo Z, et al
    Cytoplasmic RAD23B interacts with CORO1C to synergistically promote colorectal cancer progression and metastasis.
    Cancer Lett. 2021;516:13-27.
    PubMed         Abstract available

    Clin Cancer Res

  16. TAIEB J, Taly V, Henriques J, Bourreau C, et al
    Prognostic value and relation with adjuvant treatment duration of ctDNA in stage III colon cancer: a post-hoc analysis of the PRODIGE-GERCOR IDEA-France trial.
    Clin Cancer Res. 2021 Jun 3. pii: 1078-0432.CCR-21-0271.
    PubMed         Abstract available

    Clin Res Hepatol Gastroenterol

  17. ZHOU Y, Wang S, Yin X, Gao G, et al
    TSHZ3 functions as a tumor suppressor by DNA methylation in colorectal cancer.
    Clin Res Hepatol Gastroenterol. 2021 Jun 2:101725.
    PubMed         Abstract available

    Curr Treat Options Oncol

  18. PECCI F, Cantini L, Bittoni A, Lenci E, et al
    Beyond Microsatellite Instability: Evolving Strategies Integrating Immunotherapy for Microsatellite Stable Colorectal Cancer.
    Curr Treat Options Oncol. 2021;22:69.
    PubMed         Abstract available

  19. LI J, Cai Y, Deng Y
    Selection of Oral Therapeutics in China for the Treatment of Colorectal Cancer.
    Curr Treat Options Oncol. 2021;22:55.
    PubMed         Abstract available

    Dis Colon Rectum

  20. JOCHUM SB, Becerra AZ, Zhang Y, Hayden DM, et al
    Keep Them on the Table: Outcomes are Improved After Minimally Invasive Colectomy Despite Longer Operative Times in High-Risk Colon Cancer Patients.
    Dis Colon Rectum. 2021 Jun 8. pii: 00003453-900000000-99441.
    PubMed         Abstract available

  21. BOJESEN RD, Degett TH, Dalton SO, Gogenur I, et al
    High World Heath Organization Performance Status Is Associated With Short- and Long-term Outcomes After Colorectal Cancer Surgery: A Nationwide Population-Based Study.
    Dis Colon Rectum. 2021;64:851-860.
    PubMed         Abstract available

  22. LOOGMAN L, de Nes LCF, Heil TC, Kok DEG, et al
    The Association Between Modifiable Lifestyle Factors and Postoperative Complications of Elective Surgery in Colorectal Cancer Patients.
    Dis Colon Rectum. 2021 Jun 1. pii: 00003453-900000000-99448.
    PubMed         Abstract available

    Research Perspective on Classic and Novel Histopathological Risk Factors for Lymph Node Metastasis in T1 Colorectal Cancer: A Systematic Review and Meta-analysis.
    Dis Colon Rectum. 2021 Jun 8. pii: 00003453-900000000-99444.

    Eur J Cancer

  24. EL-KHOURY R, Hafliger E, Gallois C, Louafi S, et al
    Treatment with encorafenib and cetuximab of a non-anti-epidermal growth factor receptor-naive patient for BRAF V600E-mutated metastatic colon cancer.
    Eur J Cancer. 2021;152:1-3.

    Eur J Surg Oncol

  25. ROSANDER E, Holm T, Sjovall A, Hjern F, et al
    Preoperative multidisciplinary team assessment is associated with improved survival in patients with locally advanced colon cancer; a nationwide cohort study in 3157 patients.
    Eur J Surg Oncol. 2021 May 14. pii: S0748-7983(21)00484.
    PubMed         Abstract available

  26. SONODA H, Yamada T, Matsuda A, Ohta R, et al
    Elevated serum carcinoembryonic antigen level after curative surgery is a prognostic biomarker of stage II-III colorectal cancer.
    Eur J Surg Oncol. 2021 Jun 2. pii: S0748-7983(21)00536.
    PubMed         Abstract available

  27. DE KLERK M, van Dalen DH, Nahar-van Venrooij LMW, Meijerink WJHJ, et al
    A multimodal prehabilitation program in high-risk patients undergoing elective resection for colorectal cancer: A retrospective cohort study.
    Eur J Surg Oncol. 2021 May 29. pii: S0748-7983(21)00528.
    PubMed         Abstract available

  28. KASTORA SL, Osborne LL, Jardine R, Kounidas G, et al
    Non-steroidal anti-inflammatory agents and anastomotic leak rates across colorectal cancer operations and anastomotic sites: A systematic review and meta-analysis of anastomosis specific leak rate and confounding factors.
    Eur J Surg Oncol. 2021 Jun 1. pii: S0748-7983(21)00535.
    PubMed         Abstract available


  29. KEHM RD, Lima SM, Swett K, Mueller L, et al
    Age-specific trends in colorectal cancer incidence for women and men, 1935-2017.
    Gastroenterology. 2021 May 28. pii: S0016-5085(21)03072.

  30. ARAI J
    The colorectal cancer lipidome: Is there any differences of lipid species between right and left colorectal cancers?
    Gastroenterology. 2021 Jun 1. pii: S0016-5085(21)03074.

    Gastrointest Endosc

  31. DJINBACHIAN R, Marchand E, Pohl H, Aguilera-Fish A, et al
    Optical diagnosis of colorectal polyps: a randomized controlled trial comparing endoscopic image-enhancing modalities.
    Gastrointest Endosc. 2021;93:712-719.
    PubMed         Abstract available

  32. LEE CJ, Vemulapalli KC, Rex DK
    Colorectal EMR outcomes in octogenarians versus younger patients referred for removal of large (>/=20 mm) nonpedunculated polyps.
    Gastrointest Endosc. 2021;93:699-703.
    PubMed         Abstract available

  33. CHOI AY, Moosvi Z, Shah S, Roccato MK, et al
    Underwater versus conventional EMR for colorectal polyps: systematic review and meta-analysis.
    Gastrointest Endosc. 2021;93:378-389.
    PubMed         Abstract available

  34. YANG D, Perbtani YB, Wang Y, Rumman A, et al
    Evaluating learning curves and competence in colorectal EMR among advanced endoscopy fellows: a pilot multicenter prospective trial using cumulative sum analysis.
    Gastrointest Endosc. 2021;93:682-690.
    PubMed         Abstract available

  35. ARIMOTO J, Ohata K, Chiba H, Tachikawa J, et al
    Evaluation of colorectal endoscopic submucosal dissection using a multifunctional snare: a prospective clinical feasibility study (with videos).
    Gastrointest Endosc. 2021;93:671-678.
    PubMed         Abstract available

  36. RODRIGUEZ-DIAZ E, Baffy G, Lo WK, Mashimo H, et al
    Real-time artificial intelligence-based histologic classification of colorectal polyps with augmented visualization.
    Gastrointest Endosc. 2021;93:662-670.
    PubMed         Abstract available

  37. ZHAO X, Lei H, Zou S, Yao F, et al
    A case of inverted serrated polyp that mimics a submucosal tumor.
    Gastrointest Endosc. 2021;93:526-527.

  38. YAMAMOTO S, Varkey J, Bhandari P
    Acetoelectronic chromoendoscopy for sessile serrated polyp.
    Gastrointest Endosc. 2021;93:267-268.

  39. HASSAN C, Spadaccini M, Iannone A, Maselli R, et al
    Performance of artificial intelligence in colonoscopy for adenoma and polyp detection: a systematic review and meta-analysis.
    Gastrointest Endosc. 2021;93:77-85.
    PubMed         Abstract available

  40. MOHAN BP, Khan SR, Chandan S, Kassab LL, et al
    Endoscopic resection of colon dysplasia in patients with inflammatory bowel disease: a systematic review and meta-analysis.
    Gastrointest Endosc. 2021;93:59-67.
    PubMed         Abstract available

  41. BORDET M, Bretagne JF, Piette C, Rousseau C, et al
    Reappraisal of the characteristics, management, and prognosis of intramucosal colorectal cancers and their comparison with T1 carcinomas.
    Gastrointest Endosc. 2021;93:477-485.
    PubMed         Abstract available

  42. CHANDAN S, Mohan BP, Khan SR, Bhogal N, et al
    Adenoma and polyp detection rates during insertion versus withdrawal phase of colonoscopy: a systematic review and meta-analysis of randomized controlled trials.
    Gastrointest Endosc. 2021;93:68-76.
    PubMed         Abstract available

  43. ROOS VH, Bastiaansen BA, Kallenberg FGJ, Aelvoet AS, et al
    Endoscopic management of duodenal adenomas in patients with familial adenomatous polyposis.
    Gastrointest Endosc. 2021;93:457-466.
    PubMed         Abstract available

  44. LUI TKL, Hui CKY, Tsui VWM, Cheung KS, et al
    New insights on missed colonic lesions during colonoscopy through artificial intelligence-assisted real-time detection (with video).
    Gastrointest Endosc. 2021;93:193-200.
    PubMed         Abstract available

  45. MONACHESE M, Mankaney G, El-Khider F, Rouphael C, et al
    Association between baseline hyperplastic polyps and metachronous serrated lesions.
    Gastrointest Endosc. 2021;93:1401-1407.
    PubMed         Abstract available

  46. WANG L, Zhao L, Wang X
    Concerns of en bloc resection on long-term outcomes after EMR for colorectal laterally spreading tumor.
    Gastrointest Endosc. 2021;93:280-281.

  47. ZIMMER V, Eltze E
    A challenging colorectal lesion: truly intradiverticular granular-type laterally spreading tumor.
    Gastrointest Endosc. 2021;93:1187-1189.

  48. LI B, Zhong YS, Zhou PH
    Gastrointest Endosc. 2021;93:1436-1437.

  49. JACQUES J, Legros R, Wallenhorst T, Pioche M, et al
    Prediction of technically difficult, colorectal, endoscopic submucosal dissection: Is the procedural time a good endpoint?
    Gastrointest Endosc. 2021;93:1435-1436.

    Is it enough to consider the number of endoscopy cases to evaluate colon adenoma detection rates?
    Gastrointest Endosc. 2021;93:1204-1205.

  51. SINGH AD, Mehta NA, Bhatt A, Burke CA, et al
    Endoscopic papillectomy in patients with familial adenomatous polyposis: Does one size fit all?
    Gastrointest Endosc. 2021;93:1202.

  52. ROOS VH, Aelvoet AS, Bastiaansen BAJ, Fockens P, et al
    Gastrointest Endosc. 2021;93:1202-1203.

  53. SHAUKAT A, Robertson DJ, Burke CA, Cruise M, et al
    Gastrointest Endosc. 2021;93:1198-1201.

  54. GUPTA S, Lieberman D
    Gastrointest Endosc. 2021;93:994.

  55. DENIS B
    Postpolypectomy colonoscopy surveillance guidelines: small revolutions, but still room for improvement.
    Gastrointest Endosc. 2021;93:993-994.

  56. PERBTANI YB, Draganov PV, Yang D
    Gastrointest Endosc. 2021;93:777.

  57. KIDAMBI TD, Lee JK
    Validated training tools are needed for assessing competency in colorectal endoscopic mucosal resection.
    Gastrointest Endosc. 2021;93:776-777.

  58. PILONIS ND, Kaminski MF
    Will machines decipher colonoscopy quality from endoscopists' notes?
    Gastrointest Endosc. 2021;93:758-760.

  59. VISRODIA K, Sethi A
    A knife plus a snare, but how will it fare?
    Gastrointest Endosc. 2021;93:679-681.

  60. PEI Q, Qiao H, Zhang M, Wang G, et al
    Pocket-creation method versus conventional method of endoscopic submucosal dissection for superficial colorectal neoplasms: a meta-analysis.
    Gastrointest Endosc. 2021;93:1038-1046.
    PubMed         Abstract available

  61. DAS R, McGrath K
    Duodenal endotherapy in familial adenomatous polyposis: Helping, hurting, both, or neither?
    Gastrointest Endosc. 2021;93:467-469.

  62. YOSHIDA Y, Kurahara K, Yaita H, Fujioka S, et al
    Early rectal cancer with perianal pagetoid spread.
    Gastrointest Endosc. 2021;93:1189-1190.


  63. OROUJI E, Raman AT, Singh AK, Sorokin A, et al
    Chromatin state dynamics confers specific therapeutic strategies in enhancer subtypes of colorectal cancer.
    Gut. 2021 May 31. pii: gutjnl-2020-322835. doi: 10.1136/gutjnl-2020-322835.
    PubMed         Abstract available

  64. PIN-VIEITO N, Tejido-Sandoval C, de Vicente-Bielza N, Sanchez-Gomez C, et al
    Faecal immunochemical tests safely enhance rational use of resources during the assessment of suspected symptomatic colorectal cancer in primary care: systematic review and meta-analysis.
    Gut. 2021 Jun 9. pii: gutjnl-2021-324856. doi: 10.1136/gutjnl-2021-324856.
    PubMed         Abstract available

    Int J Cancer

  65. Retraction: DCLK1 promotes epithelial-mesenchymal transition via the PI3K/Akt/NF-kB pathway in colorectal cancer. Weiying Liu, Shixing Wang, Qi Sun, Zhen Yang, Min Liu and Hua Tang. Int J Cancer. 2018 May 15;142(10):2068-2079.
    Int J Cancer. 2021 Jun 1. doi: 10.1002/ijc.33671.

  66. LADIGAN-BADURA S, Vangala DB, Engel C, Bucksch K, et al
    Value of upper GI endoscopy for gastric cancer surveillance in patients with Lynch syndrome.
    Int J Cancer. 2020 Sep 15. doi: 10.1002/ijc.33294.
    PubMed         Abstract available

  67. DOMINGUEZ-VALENTIN M, Sampson JR, Moller P, Seppala TT, et al
    Analysis in the Prospective Lynch Syndrome Database identifies sarcoma as part of the Lynch syndrome tumor spectrum.
    Int J Cancer. 2021;148:512-513.

  68. WANG L, Hang D, He X, Lo CH, et al
    A prospective study of erythrocyte polyunsaturated fatty acids and risk of colorectal serrated polyps and conventional adenomas.
    Int J Cancer. 2021;148:57-66.
    PubMed         Abstract available

  69. CLIFFORD GM, Georges D, Shiels MS, Engels EA, et al
    A meta-analysis of anal cancer incidence by risk group: towards a unified anal cancer risk scale.
    Int J Cancer. 2020 Jul 4. doi: 10.1002/ijc.33185.
    PubMed         Abstract available

    Int J Colorectal Dis

  70. DOHRN N, Klein MF, Gogenur I
    Robotic versus laparoscopic right colectomy for colon cancer: a nationwide cohort study.
    Int J Colorectal Dis. 2021 Jun 2. pii: 10.1007/s00384-021-03966.
    PubMed         Abstract available

  71. DENK S, Schmidt S, Schurr Y, Schwarz G, et al
    Correction to: CIP2A regulates MYC translation (via its 5'UTR) in colorectal cancer.
    Int J Colorectal Dis. 2021 Jun 4. pii: 10.1007/s00384-021-03960.

  72. LEE JH, Ahn BK, Ryu J, Lee KH, et al
    Mechanical bowel preparation combined with oral antibiotics in colorectal cancer surgery: a nationwide population-based study.
    Int J Colorectal Dis. 2021 Jun 5. pii: 10.1007/s00384-021-03967.
    PubMed         Abstract available

  73. TRAXLER B, Walters C, Adewumi MT, Meyer C, et al
    An analysis of the rates of discontinuation and non-publication of colorectal cancer clinical trials.
    Int J Colorectal Dis. 2021 Jun 10. pii: 10.1007/s00384-021-03972.
    PubMed         Abstract available

    Int J Oncol

  74. SHEN X, Ye Z, Wu W, Zhao K, et al
    lncRNA NEAT1 facilitates the progression of colorectal cancer via the KDM5A/Cul4A and Wnt signaling pathway.
    Int J Oncol. 2021;59.
    PubMed         Abstract available

    J Am Coll Surg

  75. KAWAGUCHI Y, Kopetz S, Kwong L, Xiao L, et al
    Genomic Sequencing and Insight into Clinical Heterogeneity and Prognostic Pathway Genes in Patients with Metastatic Colorectal Cancer.
    J Am Coll Surg. 2021 Jun 3. pii: S1072-7515(21)00412.
    PubMed         Abstract available

    J Clin Oncol

  76. SCHMOLL HJ, Stein A, Van Cutsem E, Price T, et al
    Pre- and Postoperative Capecitabine Without or With Oxaliplatin in Locally Advanced Rectal Cancer: PETACC 6 Trial by EORTC GITCG and ROG, AIO, AGITG, BGDO, and FFCD.
    J Clin Oncol. 2021;39:17-29.
    PubMed         Abstract available

    J Natl Cancer Inst

  77. TEN HOORN S, de Back TR, Sommeijer DW, Vermeulen L, et al
    Clinical Value of Consensus Molecular Subtypes in Colorectal Cancer: A Systematic Review and Meta-Analysis.
    J Natl Cancer Inst. 2021 Jun 2. pii: 6291249. doi: 10.1093.
    PubMed         Abstract available

  78. YIN J, Cohen R, Jin Z, Liu H, et al
    Prognostic and Predictive Impact of Primary Tumor Sidedness for Previously Untreated Advanced Colorectal Cancer.
    J Natl Cancer Inst. 2021 Jun 1. pii: 6290718. doi: 10.1093.
    PubMed         Abstract available

    J Surg Oncol

  79. FELDMAN HA, Zhou N, Antonoff MB, Hofstetter WL, et al
    Simultaneous versus staged resections for bilateral pulmonary metastases.
    J Surg Oncol. 2021 Mar 8. doi: 10.1002/jso.26392.
    PubMed         Abstract available

  80. DREFS M, Schoenberg MB, Schiergens TS, Albertsmeier M, et al
    Chances, challenges and outcomes of patients with complex bilobar colorectal liver metastases approached by a combined multimodal therapy with liver resection and local ablative therapy.
    J Surg Oncol. 2021;123:1578-1591.
    PubMed         Abstract available

  81. KAZI M, Bhamre R, DeSouza A, Ostwal V, et al
    Long-term oncological outcomes of the sphincter preserving total mesorectal excision with varying distal resection margins.
    J Surg Oncol. 2021;123:1784-1791.
    PubMed         Abstract available

  82. BOHLOK A, Duran Derijckere I, Azema H, Lucidi V, et al
    Clinico-metabolic characterization improves the prognostic value of histological growth patterns in patients undergoing surgery for colorectal liver metastases.
    J Surg Oncol. 2021;123:1773-1783.
    PubMed         Abstract available

    Lancet Oncol

  83. Variation in the risk of colorectal cancer in families with Lynch syndrome: a retrospective cohort study.
    Lancet Oncol. 2021 Jun 7. pii: S1470-2045(21)00189.
    PubMed         Abstract available


  84. MALKOMES P, Lunger I, Oppermann E, Abou-El-Ardat K, et al
    Transglutaminase 2 promotes tumorigenicity of colon cancer cells by inactivation of the tumor suppressor p53.
    Oncogene. 2021 Jun 8. pii: 10.1038/s41388-021-01847.
    PubMed         Abstract available

  85. YOU J, Li J, Ke C, Xiao Y, et al
    Oncogenic long intervening noncoding RNA Linc00284 promotes c-Met expression by sponging miR-27a in colorectal cancer.
    Oncogene. 2021 May 28. pii: 10.1038/s41388-021-01839.
    PubMed         Abstract available

  86. MCANDREWS KM, Vazquez-Arreguin K, Kwak C, Sugimoto H, et al
    alphaSMA(+) fibroblasts suppress Lgr5(+) cancer stem cells and restrain colorectal cancer progression.
    Oncogene. 2021 Jun 9. pii: 10.1038/s41388-021-01866.
    PubMed         Abstract available

    Oncol Rep

  87. LI YF, Shi LJ, Wang P, Wang JW, et al
    Binding between ROCK1 and DCTN2 triggers diabetesassociated centrosome amplification in colon cancer cells.
    Oncol Rep. 2021;46.
    PubMed         Abstract available

  88. CHI J, Liu S, Wu Z, Shi Y, et al
    circNSUN2 promotes the malignant biological behavior of colorectal cancer cells via the miR181a5p/ROCK2 axis.
    Oncol Rep. 2021;46.
    PubMed         Abstract available

    PLoS One

  89. ABDALLA TSA, Meiners J, Riethdorf S, Konig A, et al
    Prognostic value of preoperative circulating tumor cells counts in patients with UICC stage I-IV colorectal cancer.
    PLoS One. 2021;16:e0252897.
    PubMed         Abstract available

  90. KIM HG, Yang SY, Han YD, Cho MS, et al
    Association of perioperative serum carcinoembryonic antigen level and recurrence in low-risk stage IIA colon cancer.
    PLoS One. 2021;16:e0252566.
    PubMed         Abstract available

  91. LIM TZ, Lau J, Wong GJ, Tan KK, et al
    Colorectal cancer in patients with single versus double positive faecal immunochemical test results: A retrospective cohort study from a public tertiary hospital.
    PLoS One. 2021;16:e0250460.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  92. HU S, Fang Y, Chen X, Cheng T, et al
    cGAS restricts colon cancer development by protecting intestinal barrier integrity.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

    World J Surg

  93. CAYCEDO-MARULANDA A, Patel SV, Verschoor CP, Uscategui JP, et al
    A Snapshot of the International Views of the Treatment of Rectal Cancer Patients, a Multi-regional Survey: International Tendencies in Rectal Cancer.
    World J Surg. 2021;45:302-312.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.